Clinical trial
LOWER: Lomitapide Observational Worldwide Evaluation Registry
NCT02135705 is registered in ClinicalTrials.gov with Amryt Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LOWER: Lomitapide Observational Worldwide Evaluation Registry
- Lead sponsor
- Amryt Pharma
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 18, 2014
- Completion date
- April 27, 2026
- Enrollment
- 260 (actual)
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.